301 related articles for article (PubMed ID: 9343229)
1. Rotavirus virus-like particles administered mucosally induce protective immunity.
O'Neal CM; Crawford SE; Estes MK; Conner ME
J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
[TBL] [Abstract][Full Text] [Related]
2. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.
O'Neal CM; Clements JD; Estes MK; Conner ME
J Virol; 1998 Apr; 72(4):3390-3. PubMed ID: 9525668
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.
Bertolotti-Ciarlet A; Ciarlet M; Crawford SE; Conner ME; Estes MK
Vaccine; 2003 Sep; 21(25-26):3885-900. PubMed ID: 12922123
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
5. Virus-like particles as a rotavirus subunit vaccine.
Conner ME; Zarley CD; Hu B; Parsons S; Drabinski D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Madore HP; Crawford S; Estes MK
J Infect Dis; 1996 Sep; 174 Suppl 1():S88-92. PubMed ID: 8752296
[TBL] [Abstract][Full Text] [Related]
6. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.
Ciarlet M; Crawford SE; Barone C; Bertolotti-Ciarlet A; Ramig RF; Estes MK; Conner ME
J Virol; 1998 Nov; 72(11):9233-46. PubMed ID: 9765471
[TBL] [Abstract][Full Text] [Related]
7. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.
Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME
Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709
[TBL] [Abstract][Full Text] [Related]
8. Rotavirus subunit vaccines.
Conner ME; Crawford SE; Barone C; O'Neal C; Zhou YJ; Fernandez F; Parwani A; Saif LJ; Cohen J; Estes MK
Arch Virol Suppl; 1996; 12():199-206. PubMed ID: 9015116
[TBL] [Abstract][Full Text] [Related]
9. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
[TBL] [Abstract][Full Text] [Related]
10. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL
Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.
Azevedo MS; Yuan L; Iosef C; Chang KO; Kim Y; Nguyen TV; Saif LJ
Clin Diagn Lab Immunol; 2004 Jan; 11(1):12-20. PubMed ID: 14715539
[TBL] [Abstract][Full Text] [Related]
12. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.
Madore HP; Estes MK; Zarley CD; Hu B; Parsons S; Digravio D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Crawford S; Conner ME
Vaccine; 1999 May; 17(19):2461-71. PubMed ID: 10392629
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.
Yuan L; Iosef C; Azevedo MS; Kim Y; Qian Y; Geyer A; Nguyen TV; Chang KO; Saif LJ
J Virol; 2001 Oct; 75(19):9229-38. PubMed ID: 11533185
[TBL] [Abstract][Full Text] [Related]
15. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.
Yuan L; Geyer A; Hodgins DC; Fan Z; Qian Y; Chang KO; Crawford SE; Parreño V; Ward LA; Estes MK; Conner ME; Saif LJ
J Virol; 2000 Oct; 74(19):8843-53. PubMed ID: 10982326
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity induced by rotavirus DNA vaccines.
Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
[TBL] [Abstract][Full Text] [Related]
18. Development of a Bacillus subtilis-based rotavirus vaccine.
Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
[TBL] [Abstract][Full Text] [Related]
19. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
20. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
Shuttleworth G; Eckery DC; Awram P
Arch Virol; 2005 Feb; 150(2):341-9. PubMed ID: 15578236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
